Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001229765-26-000008

Director sold 52,084 shares at $20.18 ($1,051,055)

  • Director acquired 52,084 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Exercise or conversion : show line 1 in the form 10b5-1 +52,084 $7.80 $406,255 67,709 D
2026-06-25 Sale : show line 2 in the form 10b5-1 −52,084 $20.18 $1,051,055 15,625 D
Open-market sales · 52,084 sh · avg $20.18 · $1,051,055

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-25 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −52,084 0 D
Loading xslF345X06/form4.xml…